ebm medical tirzepatide (Zepbound) for the Treatment of Obesity Tirzepatide for diabetes: on track

N Engl J Med 356:24572471 Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR (2003) Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-y ligand rosiglitazone

Limited data from studies conducted with the phentermine/topiramate combination indicate that phentermine alone was not teratogenic but resulted in lower body weight and reduced survival of offspring in rats at 5-fold the MRHD of QSYMIA, based on AUC

It is important to note that whilst GLP-1 receptor agonists are not specifically licensed for "menopausal weight gain" as a distinct indication, they may be prescribed for women meeting criteria for obesity treatment or type 2 diabetes management during the menopausal transition

As India's only legally approved GLP-1 provider, it ensures safe access to Semaglutide and Liraglutide under expert medical supervision

This level of flexibility makes it easier to maintain a consistent supply without accumulating unnecessary bottles or worrying about frequent reorders

If you have more severe symptoms such as confusion, loss of consciousness, or seizures, call 911 immediately